After evaluation of these IHC markers, our results suggested that the IHC score based on the combined expression of the four markers (CK, Ki-67, p16, and p40) can predict survival in HNSCC patients. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.